Tag: galux
-
Galux and Boehringer Ingelheim Forge AI-Driven Protein Design Collaboration
Galux and Boehringer Ingelheim Announce Strategic Research Agreement Galux, a South Korean biotech innovator specializing in AI-driven protein therapeutics discovery, has entered a strategic research agreement with Boehringer Ingelheim. The collaboration aims to jointly explore and advance AI-assisted protein design, with a focus on accelerating the identification and optimization of novel therapeutic candidates. The partnership…
-
Galux and Boehringer Ingelheim Partner on AI Protein Design
Galux Collaborates with Boehringer Ingelheim to accelerate AI-driven protein design South Korea’s Galux, a biotech startup focused on AI-powered protein therapeutics discovery, has entered a strategic research agreement with Boehringer Ingelheim. The collaboration aims to explore and advance artificial intelligence technologies that can design novel protein therapeutics with improved efficacy, safety, and development timelines. The…
-
Galux and Boehringer Ingelheim Forge AI-Driven Protein Design Partnership
Overview of the Collaboration Galux, a South Korean biotechnology company pioneering artificial intelligence in protein therapeutics discovery, has announced a research agreement with Boehringer Ingelheim. The collaboration aims to explore and advance AI-driven protein design to accelerate the development of novel biologics and peptide therapies. This partnership reflects a broader industry shift toward leveraging advanced…